Tarsons Products submits voting results and scrutinizer report of 43rd AGM

Compliance View source PDF Explain this filing

TARSONS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-2.4%Reaction day

₹335.50

prior close

₹339.90

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.0%-3.4% vs market

Medical Equipment & Supplies peers, median of 12sector+0.6%-3.0% vs sector

On the reaction day the stock moved 3.4 pts less than Nifty Microcap 250 and 3.0 pts less than its Medical Equipment & Supplies peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.4

10m

-0.8

15m

-1.0

30m

+0.2

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-2.4+1.0-3.4+0.6-3.0

Next day

-4.6+0.8-5.4+0.0-4.6

-1.3-0.5-0.7-0.3-0.9

-0.2-0.5+0.4-1.1+0.9

-1.3+0.8-2.1-0.3-1.0

+1.8+0.5+1.2-2.2+4.0

-4.5-2.0-2.6-7.1+2.6

15d

-8.7-6.4-2.3-10.1+1.4

—————

UpDownMarket · Nifty Microcap 250Sector · Medical Equipment & Supplies peers, median of 12Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

All 5 resolutions at the 43rd AGM held on September 24, 2026 via video conferencing were passed with requisite majority. Items include adoption of audited standalone and consolidated financials for FY ending March 31, 2026, re-appointment of Mr. Sanjive Sehgal, approval of material related party transactions with step-down subsidiary Nerbe Plus GmbH, and waiver of excessive managerial remuneration paid to directors in FY 2025-26.

Likely market impact

Routine AGM result. All resolutions passed including RPT approval with German subsidiary and waiver of excess director pay. No material stock impact expected.